Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2022
Twist Bioscience prices $250 million public offering
Twist Bioscience announced pricing for an upsized public offering of 4,545,454 common shares at $55.00 per share, with gross proceeds expected to be approximately $250 million before expenses and underwriting discounts.
2020
Twist Bioscience appoints Erin Smith as senior vice president
Twist Bioscience announced Erin Smith's appointment to the newly created position of senior vice president of government affairs and public policy.